Partner Content | 05 January 2022 | Influencers

Plasmid DNA as a starting material for large-scale mRNA vaccines from the PlasmidFactory

  You have been working in plasmid research and production for 20 years and were immediately ava...Read more

Singapore | 07 October 2021 | Opinion

"The future of patient care could potentially be on a completely remote basis"

BioSpectrum Asia spoke to Benjamin Low, Vice-President, Asia Pacific, Milestone Systems, on how Singapore and ...Read more

Japan | 19 January 2022 | News

IQVIA releases emerging biotech/biopharma trends to watch for in 2022

IQVIA has come up with the key trends that emerging biotech and emerging biopharma companies should look out f...Read more

India | 19 January 2022 | News

Indian pharma major Lupin inks partnership agreement with Foncoo for China

India-based Lupin has entered into a partnership with Shenzhen Foncoo Pharmaceutical Co Ltd (Foncoo). This is ...Read more

Australia | 19 January 2022 | News

Australia to launch first collaborative cardiovascular research accelerator

Federal Minister for Health, Greg Hunt has announced funding for two new Research Centres through the MTPConne...Read more

Singapore | 17 January 2022 | News

Singapore deepens interest in dengue virus transmission

Software-analysed high-resolution videos have revealed that dengue-infected mosquitos are more attracted to ma...Read more

China | 19 January 2022 | News

China approves world's first artificial cornea of 100% non-biological materials

MIOK Keratoprosthesis has been approved for listing by National Medical Products Administration (NMPA), the Ch...Read more

China | 17 January 2022 | News

Hong Kong develops anti-virus 3D printing material to rapidly terminate COVID-19

An interdisciplinary research team from The Hong Kong Polytechnic University (PolyU) has successfully develope...Read more

Korea | 11 January 2022 | News

South Korea-based SK Inc. invests $350 M in ‘Centre for Breakthrough Medicines’

The Centre for Breakthrough Medicines (CBM), based in the US, has received $350 million in equity financing fr...Read more

World | 29 October 2021 | News

MilliporeSigma advances next generation antibody-drug conjugate therapies

MilliporeSigma, the U.S. and Canadian Life Science business of Merck KGaA, Darmstadt, Germany, a leading ...Read more